SM

Savita M Patil

Active Director Whole-Time Director DIN 07989143
DIN 07989143 First appointment Jan 2018 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Jan 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Savita M Patil

Data last updated:

Savita M Patil is a Whole-Time Director at Hombelaku Pharmaceuticals Private Limited (since 2025) and Director at Takis Lifesciences Private Limited (since 2018). The companies operate in Pharma and Trading.

DIN 07989143
Primary Designation Whole-Time Director
Industry Pharma
First Appointment 01 Jan 2018
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Whole-Time Director15 Feb 20252025Active
Takis Lifesciences Private Limited U51909KA2018PTC109092
Director01 Jan 20182018Active

Board colleagues of Savita M Patil

Directorship timeline

Open interactive timeline →
Hombelaku Pharmaceuticals Private Limited
Takis Lifesciences Private Limited
Premium access

Shareholding and investment profile for Savita M Patil

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Savita M Patil

Savita M Patil currently holds 2 directorships: Hombelaku Pharmaceuticals Private Limited (Whole-Time Director, since 15 Feb 2025); Takis Lifesciences Private Limited (Director, since 01 Jan 2018).

Savita M Patil was first appointed on 01 Jan 2018 as Director at Takis Lifesciences Private Limited. The most recent appointment on record is 15 Feb 2025 at Hombelaku Pharmaceuticals Private Limited.

The current boards of Savita M Patil's companies include Ane Madagu Narayana Reddy Sujatha (Hombelaku Pharmaceuticals Private Limited), Kalpana Devalla (Takis Lifesciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available